1 Min Read
May 15 (Reuters) - Cynata Therapeutics Ltd:
* Company requests trading halt pending an announcement in relation to company’s Phase 1 clinical trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.